{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:46:16Z","timestamp":1789908376403,"version":"4.0.1"},"reference-count":20,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["HIV Clinical Trials"],"published-print":{"date-parts":[[2017,7,4]]},"DOI":"10.1080\/15284336.2017.1370059","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T12:57:40Z","timestamp":1505134660000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Week 48 resistance analysis of Elvitegravir\/Cobicistat\/Emtricitabine\/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine\/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128)"],"prefix":"10.1080","volume":"18","author":[{"given":"Rima","family":"Kulkarni","sequence":"first","affiliation":[{"name":"Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-5550","authenticated-orcid":false,"given":"Sally L.","family":"Hodder","sequence":"additional","affiliation":[{"name":"Health Sciences Center, West Virginia Clinical and Translational Science Institute Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Cao","sequence":"additional","affiliation":[{"name":"Clinical Research, Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chang","sequence":"additional","affiliation":[{"name":"Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Miller","sequence":"additional","affiliation":[{"name":"Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"White","sequence":"additional","affiliation":[{"name":"Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"CIT0001","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Global aids update 2016. Available at: https:\/\/www.unaids.org\/en\/resources\/documents\/2016\/Global-AIDS-update-2016. May 31, 2016."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1126\/science.7638593"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307223290428"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2011.0278"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.2012.13.issue-7"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2647"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.2.273"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-153-6-201009210-00002"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283390db3"},{"key":"CIT0010","unstructured":"European AIDS Clinical Society (EACS). Guidelines version 8.1 English; 2016 October."},{"key":"CIT0011","unstructured":"Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Developed by the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents \u2013 A Working Group of the Office of AIDS Research Advisory Council (OARAC). Available at: https:\/\/aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Revised November 13, 2014."},{"key":"CIT0012","unstructured":"World Health Organization (WHO). Consolidation guidelines on HIV prevention, diagnosis, treatment and care for key populations; 2016."},{"key":"CIT0013","unstructured":"Department of Health and Human Services (DHHS). Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States; 2014 March 28."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2742"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(16)30016-9"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.3390\/v7122943"},{"key":"CIT0017","unstructured":"International Antiviral Society-USA (IAS-USA). Update of the drug resistance mutations in HIV-1. Available at: https:\/\/www.iasusa.org\/content\/drug-resistance-mutations-in-HIV. Accessed: February 2, 2017."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0123"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60918-0"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817bbe93"}],"container-title":["HIV Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15284336.2017.1370059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:40:45Z","timestamp":1599349245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15284336.2017.1370059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7,4]]}},"alternative-id":["10.1080\/15284336.2017.1370059"],"URL":"https:\/\/doi.org\/10.1080\/15284336.2017.1370059","relation":{},"ISSN":["1528-4336","1945-5771"],"issn-type":[{"value":"1528-4336","type":"print"},{"value":"1945-5771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}